News Release

Study reveals “day zero” testing strategy to transform future pandemic response

Reports and Proceedings

American Society for Microbiology

Washington, D.C. – June 11, 2022 – The immense toll of the COVID-19 pandemic was in large part due to a lack of preparedness, including a significant delay in developing and deploying effective testing strategies. New research, presented at ASM Microbe 2022, highlights the potential of the Jumpcode Genomics CRISPRclean™ technology for transforming the response of future large-scale pandemics through testing that is highly sensitive, pathogen-agnostic and can be deployed on “Day Zero” – at the time of the first reported case.

Researchers from Jumpcode Genomics and the Translational Genomics Research Institute (TGen) evaluated the potential of CRISPRclean technology – which combines CRISPR-based technology and next-generation sequencing (NGS) – to overcome constraints of traditional NGS, such as the limited ability to detect low levels of pathogens due to abundant sequences with little biological meaning. Results of the study reveal that by using CRISPRclean to remove abundant sequences that are not important, the assay can quickly identify variant strain types, co-infections, and individual human host response, in a single workflow.

“By significantly increasing the sensitivity of infectious disease testing strategies, CRISPRclean technology has transformative potential for identifying and tracking any pathogen and variant while providing public health professionals with vital and timely information,” said Keith Brown, Founder and CTO of Jumpcode Genomics.



ASM Microbe is the annual meeting of the American Society for Microbiology, held June 9-13, 2022, in Washington, D.C.

The American Society for Microbiology is one of the largest professional societies dedicated to the life sciences and is composed of 30,000 scientists and health practitioners. ASM's mission is to promote and advance the microbial sciences.  

ASM advances the microbial sciences through conferences, publications, certifications, educational opportunities and advocacy efforts. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences. 

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.